Yorkie Promotes Transcription by Recruiting a Histone Methyltransferase Complex

Cell Reports

Volumn 8, Issue 2, 2014, Pages 449-459

  Oh, Hyangyee ^a   Slattery, Matthew ^b,c,d   Ma, Lijia ^c   White, Kevin P ^c   Mann, Richard S ^b   Irvine, Kenneth D ^a  

^a RUTGERS UNIVERSITY   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE H3; HISTONE METHYLTRANSFERASE; NCOA6; TRANSCRIPTION FACTOR; TRANSCRIPTIONAL COACTIVATOR YAP; TRANSCRIPTIONAL COACTIVATOR YORKIE; UNCLASSIFIED DRUG; CHROMATIN; DROSOPHILA PROTEIN; NCOA6 PROTEIN, DROSOPHILA; NUCLEAR PROTEIN; NUCLEAR RECEPTOR COACTIVATOR; PROTEIN BINDING; TRANSACTIVATOR PROTEIN; YORKIE PROTEIN, DROSOPHILA; HISTONE H3K4; NCOA6 PROTEIN; TRANSCRIPTION FACTOR YAP; YORKIE PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CELL ASSAY; CELL CULTURE; CELL PROLIFERATION; CHROMATIN; CONTROLLED STUDY; EMBRYO; ENZYME SUBUNIT; GENETIC TRANSCRIPTION; HIPPO SIGNALING; HISTONE METHYLATION; HUMAN; HUMAN CELL; IN VIVO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN MOTIF; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; ANIMAL; BINDING SITE; CHEMISTRY; DROSOPHILA; GENETICS; METABOLISM; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMOSOMAL LOCALIZATION; PROTEIN PROTEIN INTERACTION;

MAMMALIA;

AMINO ACID MOTIFS; ANIMALS; BINDING SITES; CHROMATIN; DROSOPHILA; DROSOPHILA PROTEINS; NUCLEAR PROTEINS; NUCLEAR RECEPTOR COACTIVATORS; PROTEIN BINDING; TRANS-ACTIVATORS; TRANSCRIPTIONAL ACTIVATION;

EID: 84904803614     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.06.017     Document Type: Article

References (55)

1. Antonson P., Schuster G.U., Wang L., Rozell B., Holter E., Flodby P., Treuter E., Holmgren L., Gustafsson J.A. Inactivation of the nuclear receptor coactivator RAP250 in mice results in placental vascular dysfunction. Mol. Cell. Biol. 2003, 23:1260-1268.
2. Ardehali M.B., Mei A., Zobeck K.L., Caron M., Lis J.T., Kusch T. Drosophila Set1 is the major histone H3 lysine 4 trimethyltransferase with role in transcription. EMBO J. 2011, 30:2817-2828.
3. Attisano L., Wrana J.L. Signal integration in TGF-β, WNT, and Hippo pathways. F1000Prime Rep. 2013, 5:17.
4. Bayarmagnai B., Nicolay B.N., Islam A.B.M.M.K., Lopez-Bigas N., Frolov M.V. Drosophila GAGA factor is required for full activation of the dE2f1-Yki/Sd transcriptional program. Cell Cycle 2012, 11:4191-4202.
5. Blaumueller C.M., Mlodzik M. The Drosophila tumor suppressor expanded regulates growth, apoptosis, and patterning during development. Mech. Dev. 2000, 92:251-262.
6. Brennecke J., Hipfner D.R., Stark A., Russell R.B., Cohen S.M. bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell 2003, 113:25-36.
7. Chan S.W., Lim C.J., Huang C., Chong Y.F., Gunaratne H.J., Hogue K.A., Blackstock W.P., Harvey K.F., Hong W. WW domain-mediated interaction with Wbp2 is important for the oncogenic property of TAZ. Oncogene 2011, 30:600-610.
8. Cho E., Feng Y., Rauskolb C., Maitra S., Fehon R., Irvine K.D. Delineation of a Fat tumor suppressor pathway. Nat. Genet. 2006, 38:1142-1150.
9. Eissenberg J.C., Shilatifard A. Histone H3 lysine 4 (H3K4) methylation in development and differentiation. Dev. Biol. 2010, 339:240-249.
10. Goo Y.H., Sohn Y.C., Kim D.H., Kim S.W., Kang M.J., Jung D.J., Kwak E., Barlev N.A., Berger S.L., Chow V.T., et al. Activating signal cointegrator 2 belongs to a novel steady-state complex that contains a subset of trithorax group proteins. Mol. Cell. Biol. 2003, 23:140-149.
11. Groth A.C., Fish M., Nusse R., Calos M.P. Construction of transgenic Drosophila by using the site-specific integrase from phage phiC31. Genetics 2004, 166:1775-1782.
12. Guan X.Y., Xu J., Anzick S.L., Zhang H., Trent J.M., Meltzer P.S. Hybrid selection of transcribed sequences from microdissected DNA: isolation of genes within amplified region at 20q11-q13.2 in breast cancer. Cancer Res. 1996, 56:3446-3450.
13. Hallson G., Hollebakken R.E., Li T., Syrzycka M., Kim I., Cotsworth S., Fitzpatrick K.A., Sinclair D.A., Honda B.M. dSet1 is the main H3K4 di- and tri-methyltransferase throughout Drosophila development. Genetics 2012, 190:91-100.
14. Harvey K.F., Zhang X., Thomas D.M. The Hippo pathway and human cancer. Nat. Rev. Cancer 2013, 13:246-257.
15. Herz H.M., Mohan M., Garruss A.S., Liang K., Takahashi Y.H., Mickey K., Voets O., Verrijzer C.P., Shilatifard A. Enhancer-associated H3K4 monomethylation by Trithorax-related, the Drosophila homolog of mammalian Mll3/Mll4. Genes Dev. 2012, 26:2604-2620.
16. Hong W., Guan K.L. The YAP and TAZ transcription co-activators: key downstream effectors of the mammalian Hippo pathway. Semin. Cell Dev. Biol. 2012, 23:785-793.
17. Huang J., Wu S., Barrera J., Matthews K., Pan D. The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP. Cell 2005, 122:421-434.
18. Irvine K.D. Integration of intercellular signaling through the Hippo pathway. Seminars in Cell &. Dev. Biol. 2012, 23:812-817.
19. Jiang H., Lu X., Shimada M., Dou Y., Tang Z., Roeder R.G. Regulation of transcription by the MLL2 complex and MLL complex-associated AKAP95. Nat. Struct. Mol. Biol. 2013, 20:1156-1163.
20. Johnston D.M., Sedkov Y., Petruk S., Riley K.M., Fujioka M., Jaynes J.B., Mazo A. Ecdysone- and NO-mediated gene regulation by competing EcR/Usp and E75A nuclear receptors during Drosophila development. Mol. Cell 2011, 44:51-61.
21. Kanda H., Nguyen A., Chen L., Okano H., Hariharan I.K. TheDrosophila ortholog of MLL3 and MLL4, trithorax related, functions as a negative regulator of tissue growth. Mol. Cell. Biol. 2013, 33:1702-1710.
22. Kharchenko P.V., Alekseyenko A.A., Schwartz Y.B., Minoda A., Riddle N.C., Ernst J., Sabo P.J., Larschan E., Gorchakov A.A., Gu T., et al. Comprehensive analysis of the chromatin landscape in Drosophila melanogaster. Nature 2011, 471:480-485.
23. Koontz L.M., Liu-Chittenden Y., Yin F., Zheng Y., Yu J., Huang B., Chen Q., Wu S., Pan D. The Hippo effector Yorkie controls normal tissue growth by antagonizing scalloped-mediated default repression. Dev. Cell 2013, 25:388-401.
24. Kuang S.Q., Liao L., Zhang H., Pereira F.A., Yuan Y., DeMayo F.J., Ko L., Xu J. Deletion of the cancer-amplified coactivator AIB3 results in defective placentation and embryonic lethality. J.Biol. Chem. 2002, 277:45356-45360.
25. Lee S.K., Anzick S.L., Choi J.E., Bubendorf L., Guan X.Y., Jung Y.K., Kallioniemi O.P., Kononen J., Trent J.M., Azorsa D., et al. A nuclear factor, ASC-2, as a cancer-amplified transcriptional coactivator essential for ligand-dependent transactivation by nuclear receptors invivo. J.Biol. Chem. 1999, 274:34283-34293.
26. Lee S., Lee D.K., Dou Y., Lee J., Lee B., Kwak E., Kong Y.Y., Lee S.K., Roeder R.G., Lee J.W. Coactivator as a target gene specificity determinant for histone H3 lysine 4 methyltransferases. Proc. Natl. Acad. Sci. USA 2006, 103:15392-15397.
27. Lee J.-E., Wang C., Xu S., Cho Y.-W., Wang L., Feng X., Baldridge A., Sartorelli V., Zhuang L., Peng W., Ge K. H3K4 mono- and di-methyltransferase MLL4 is required for enhancer activation during cell differentiation. eLife 2013, 2:e01503.
28. Li B., Carey M., Workman J.L. The role of chromatin during transcription. Cell 2007, 128:707-719.
29. Mahajan M.A., Samuels H.H. Nuclear receptor coactivator/coregulator NCoA6(NRC) is a pleiotropic coregulator involved in transcription, cell survival, growth and development. Nucl. Recept. Signal. 2008, 6:e002.
30. Mahajan M.A., Das S., Zhu H., Tomic-Canic M., Samuels H.H. The nuclear hormone receptor coactivator NRC is a pleiotropic modulator affecting growth, development, apoptosis, reproduction, and wound repair. Mol. Cell. Biol. 2004, 24:4994-5004.
31. Mohan M., Herz H.M., Smith E.R., Zhang Y., Jackson J., Washburn M.P., Florens L., Eissenberg J.C., Shilatifard A. The COMPASS family of H3K4 methylases in Drosophila. Mol. Cell. Biol. 2011, 31:4310-4318.
32. Oh H., Irvine K.D. Invivo regulation of Yorkie phosphorylation andlocalization. Development 2008, 135:1081-1088.
33. Oh H., Irvine K.D. Invivo analysis of Yorkie phosphorylation sites. Oncogene 2009, 28:1916-1927.
34. Oh H., Irvine K.D. Yorkie: the final destination of Hippo signaling. Trends Cell Biol. 2010, 20:410-417.
35. Oh H., Irvine K.D. Cooperative regulation of growth by Yorkie and Mad through bantam. Dev. Cell 2011, 20:109-122.
36. Oh H., Slattery M., Ma L., Crofts A., White K.P., Mann R.S., Irvine K.D. Genome-wide association of Yorkie with chromatin and chromatin-remodelingcomplexes. Cell Reports 2013, 3:309-318.
37. Peng H.W., Slattery M., Mann R.S. Transcription factor choice in the Hippo signaling pathway: homothorax and yorkie regulation of the microRNA bantam in the progenitor domain of the Drosophila eye imaginal disc. Genes Dev. 2009, 23:2307-2319.
38. Potter C.J., Tasic B., Russler E.V., Liang L., Luo L. The Q system: a repressible binary system for transgene expression, lineage tracing, and mosaic analysis. Cell 2010, 141:536-548.
39. Reddy B.V., Irvine K.D. The Fat and Warts signaling pathways: new insights into their regulation, mechanism and conservation. Development 2008, 135:2827-2838.
40. Ruthenburg A.J., Allis C.D., Wysocka J. Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark. Mol. Cell 2007, 25:15-30.
41. Salah Z., Aqeilan R.I. WW domain interactions regulate the Hippo tumor suppressor pathway. Cell Death Dis. 2011, 2:e172.
42. Sedkov Y., Cho E., Petruk S., Cherbas L., Smith S.T., Jones R.S., Cherbas P., Canaani E., Jaynes J.B., Mazo A. Methylation at lysine 4 of histone H3 in ecdysone-dependent development of Drosophila. Nature 2003, 426:78-83.
43. Shilatifard A. The COMPASS family of histone H3K4 methylases: mechanisms of regulation in development and disease pathogenesis. Annu. Rev. Biochem. 2012, 81:65-95.
44. Smith E., Shilatifard A. The chromatin signaling pathway: diverse mechanisms of recruitment of histone-modifying enzymes and varied biological outcomes. Mol. Cell 2010, 40:689-701.
45. Staley B.K., Irvine K.D. Hippo signaling in Drosophila: recent advances and insights. Dev. Dyn. 2012, 241:3-15.
46. Varelas X., Sakuma R., Samavarchi-Tehrani P., Peerani R., Rao B.M., Dembowy J., Yaffe M.B., Zandstra P.W., Wrana J.L. TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal. Nat. Cell Biol. 2008, 10:837-848.
47. Venken K.J., Carlson J.W., Schulze K.L., Pan H., He Y., Spokony R., Wan K.H., Koriabine M., de Jong P.J., White K.P., et al. Versatile P[acman] BAC libraries for transgenesis studies in Drosophila melanogaster. Nat. Methods 2009, 6:431-434.
48. Vicent G.P., Nacht A.S., Font-Mateu J., Castellano G., Gaveglia L., Ballaré C., Beato M. Four enzymes cooperate to displace histone H1 during the first minute of hormonal gene activation. Genes Dev. 2011, 25:845-862.
49. Yu F.X., Guan K.L. The Hippo pathway: regulators and regulations. Genes Dev. 2013, 27:355-371.
50. Zhang L., Ren F., Zhang Q., Chen Y., Wang B., Jiang J. The TEAD/TEF family of transcription factor Scalloped mediates Hippo signaling in organ size control. Dev. Cell 2008, 14:377-387.
51. Zhang X., Milton C.C., Humbert P.O., Harvey K.F. Transcriptional output of the Salvador/warts/hippo pathway is controlled in distinct fashions in Drosophila melanogaster and mammalian cell lines. Cancer Res. 2009, 69:6033-6041.
52. Zhang X., Milton C.C., Poon C.L., Hong W., Harvey K.F. Wbp2 cooperates with Yorkie to drive tissue growth downstream of the Salvador-Warts-Hippo pathway. Cell Death Differ. 2011, 18:1346-1355.
53. Zhang X., Grusche F.A., Harvey K.F. Control of tissue growth and cell transformation by the Salvador/Warts/Hippo pathway. PLoS ONE 2012, 7:e31994.
54. Zhao B., Kim J., Ye X., Lai Z.C., Guan K.L. Both TEAD-binding and WW domains are required for the growth stimulation and oncogenic transformation activity of yes-associated protein. Cancer Res. 2009, 69:1089-1098.
55. Zhu Y.J., Crawford S.E., Stellmach V., Dwivedi R.S., Rao M.S., Gonzalez F.J., Qi C., Reddy J.K. Coactivator PRIP, the peroxisome proliferator-activated receptor-interacting protein, is a modulator of placental, cardiac, hepatic, and embryonic development. J.Biol. Chem. 2003, 278:1986-1990.